Part II: CRISPR for Angelman syndrome
David Gurzick, PhD Barb Bailus, PhD In a recent post, we introduced gene editing technologies with a focus on CRISPR (haven’t seen it? – it’s available
David Gurzick, PhD Barb Bailus, PhD In a recent post, we introduced gene editing technologies with a focus on CRISPR (haven’t seen it? – it’s available
If you did NOT receive an email, but your name is listed below, please email kelly@cureangelman.es to claim your tickets for the 2019 FAST Gala. Names are al
Barb Bailus, PhD David Gurzick, PhD Hello Everyone, Over the next few weeks, we are going to be looking at the technology behind many of the gene therapy tec
Barb Bailus, PhD Hello Everyone! Today we are going to spend some time reviewing the various phases of drug discovery and clinical trials, which can allow fo
Barb Bailus,PhD Hello Everyone! Today we want to congratulate our FIRE team member Dr. Anne Anderson for being awarded a highly competitive Million Dollar Bi
Barb Bailus, PhD It may seem odd that FAST has added an HIV expert to the SAB, but Dr. Joseph Anderson also specializes in stem cells and unique delivery met
Barb Bailus, PhD As FAST funded science moves toward clinical trials, it has become essential to add SAB members that are familiar with the process of human
Barb Bailus, PhD With the introduction of the newest AS animal model, the FAST funded LEGEND-rat, it was time to add “rat whisperer” Dr. Jill Silverman t
Barb Bailus, PhD Dr. Cristina Alberini is an international addition to the FAST SAB, hailing from Italy. Dr. Alberini received her PhD from University of Gen
Barb Bailus, PhD FAST is always on the lookout for excellent physicians who interact with AS patients and can help design and explain what is feasible in a c